Active Ingredient: IBANDRONATE SODIUM
Proprietary Name: IBANDRONATE SODIUM
Dosage Form; Route of Administration: TABLET; ORAL
Strength: EQ 150MG BASE
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A206887
Product Number: 001
Approval Date: Oct 31, 2017
Applicant Holder Full Name: MACLEODS PHARMACEUTICALS LTD
Marketing Status:
Prescription
Patent and Exclusivity Information